Jay Lichter, 10% Owner at Janux Therapeutics, Inc. (JANX), sold 7,630 shares at $46.68 ($356K) on 2024-09-13, disclosed to the SEC on 2024-10-24.
Open-market sale of $356k JANX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.68 | 3,815 | $178K | 50.0% |
| 2 | $46.68 | 3,815 | $178K | 50.0% |
| Total | $46.68 avg | 7,630 | $356K | 100% |
| Filing → |
| JANX | BUY | 2021-06-16 | $10.7M | — | Filing → |
| OTIC | SELL | 2021-03-03 | $1.7M | — | Filing → |
| OTIC | SELL | 2021-03-02 | $5.1M | — | Filing → |